跳至主要内容
临床试验/CTRI/2019/01/016863
CTRI/2019/01/016863已完成2 期

An open label randomised clinical trial to determine the add on effect of Mustadi kwath along with Meshashringi (gymnema sylvestre) churna in the management of Diabetes Mellitus (type 2)

All India Institute Of ayurveda0 个研究点目标入组 56 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with classical signs and symptoms of Prameh/Madhumeha as stated below
  • Prabhuta Mutrata, Avila Mutrata, Pipasadhikya, Alasya, Utsahahani, Kshudhadhikya, Pindikodveshthana, Karapadatala Suptata, Daurbalya, Nidradhikya and Purishabadhdhata.
  • Criteria for diagnosis of DM by American Diabetes Association
  • Patients with random blood sugar level (RBS) >200 mg/dl, or
  • Fasting blood sugar (FBS) >126 mg/dl up to 375 mg/dl, or or
  • Postprandial blood sugar (PPBS) >200 mg/dl up to 500 mg/dl, and
  • Glycosylated haemoglobin > 6.5%.
  • Newly /Early diagnosed cases to be included as per following criteria:
  • Patients who are not taking any treatment for diabetes.
  • Patients who are not taking any conventional medicine for more than two months, whose sugar levels are raised and fall within the inclusive criteria mentioned above and are willing to take Ayurvedic treatment
  • Patient accidently diagnosed in routine check-up or when appeared with other complaints in the hospital.
  • Early diagnosed diabetic patients (less than 1yrs of history) who are asymptomatic and not taking any pharmacological drugs since last two months.

排除标准

  • Patients less than 30 years and more than 65 years
  • Emergency cases in DM
  • Patients having insulin dependent DM (IDDM) and receiving insulin (type 1)
  • Excessive blood glucose: FBS > 375 mg/dl and PPBS > 500 mg/dl
  • Chronic complications like microvascular and macrovascular.
  • Patients with any anti-diabetic pharmacological drugs
  • Patients reporting to be hypersensitive to any of the proposed trial drug.

研究者

相似试验